期刊文献+

灵芝三萜单体细胞保护与自噬诱导活性比较 被引量:2

The Different Effects of Ganoderma Triperpenoids on Cytoprotection and Autophagy Induction in PC12 Cells
下载PDF
导出
摘要 比较不同灵芝三萜单体对PC12细胞保护和自噬诱导活性的差异。结果表明,灵芝酸A、B、C、C2、DM、K对H2O2诱导的细胞损伤最大保护率分别为32.83%、12.63%、53.03%、30.30%、2.53%和25.25%;对Aβ25-35诱导的细胞损伤最大保护率分别为6.74%、29.02%、23.81%、25.07%、10.15%和5.12%;自噬诱导最大阳性率分别达到22.33%、32.67%、35.50%、28.33%、11.83%和29.50%。不同灵芝三萜单体的活性也有明显的差异,且各单体在不同活性方面均未表现出一致的强弱关系。 The different effects of C,.anoderrna triperpenoids on cytoprotection and autophag'y induction in PC12 cells were studied. The results showed that the maximum protection rates of Ganoderie acid A, B, C, C2, DM, K on H2O2 induced toxicity were 32. 83%, 12. 63%, 53.03%, 30. 30%, 2. 53% and 25.25%, respectively. The maximum protection rates on Aβ25-35 induced toxicity were 6. 74%, 29. 02%, 23.81%, 25.07%, 10. 15% and 5.12%, respectively. The maximum autophagy induction rates were 22. 33%, 32. 67%, 35.50%, 281 33%, 11.83% and 29. 50%, respectively. There was a very significant difference in C, anoderma triperpenoids on eytoprotection and autophagy induction, and the rankings of a certain triperpenoid were varied in different activity tests.
出处 《中国食用菌》 2013年第6期32-35,共4页 Edible Fungi of China
基金 四川省科技厅科技支撑计划"治疗老年痴呆症的中药五类新药候选药物研究"(2011SZ0061) 四川省中医药管理局青年中医药课题"筛选治疗神经退行性疾病中药有效成分(部位)的高通量自噬检测细胞模型的构建"(2012-E-053) 四川省中医药科学院基本科研业务专项"基于自噬快速检测细胞模型的中药治疗神经退行性疾病有效成分(部位)高通量筛选方法的构建"(A-2011N-10)
关键词 灵芝 三萜 阿尔茨海默症 神经保护 Gartoderma Triperpenoids Alzheimer' s Disease Neuroproteetion Autophagy
  • 相关文献

参考文献14

  • 1Boh B, Berovic M, Zhang JS, et al. Ganoderma lucidum and its phar- maceutically active compounds [ J ]. Biotechnology Annual Review, 2007 (13): 265-301.
  • 2周子懿,唐宇平,金惠铭,王中,森昌夫,蔡定芳.灵芝防治神经系统疾病的实验研究进展[J].上海中医药杂志,2008,42(7):92-94. 被引量:8
  • 3Shiao MS. Natural products of the medicinal fungus Ganoderma lucid- um: occurrence, biological activities, and pharmacological functions [J]. The Chemical Record, 2003 (3) : 172-180.
  • 4黄勇攀,刘丙进,喻南慧,刘鲜林,孔祥林,罗俊.灵芝三萜类化合物对AD模型大鼠脑组织保护作用的研究[J].贵阳医学院学报,2008,33(6):662-664. 被引量:6
  • 5曾祥丽,包海鹰.灵芝三萜类成分与药理学研究进展[J].菌物研究,2004,2(1):68-77. 被引量:65
  • 6Huang YD, Mucke L. Alzheimer mechanisms and therapeutic strate- gies [J]. Cell, 2012 (48): 1204-1222.
  • 7Feng Y, Wang XC. Antioxidant therapies for Alzheimer' s disease [ J ]. Oxidative Medicine and Cellular Longevity, 2012 : 472923.
  • 8Pimplikar SW. Reassessing the amyloid cascade hypothesis of Alzhei- met' s disease [J]. The International Journal of Biochemistry and Cell Biology, 2009, 41 (6) : 1261-1268.
  • 9Nunomura A, Castellani RJ, Zhu X, et al. Involvement of oxidative stress in Alzheimer disease [ J ]. Journal of Neuropathology and Ex- perimental Neurology, 2006, 65 (7) : 631 - 641.
  • 10Perry G, Cash AD, Smith MA. Alzheimer disease and oxidative stress [ J ]. Journal of Biomedicine and Biotechnology, 2002, 2 (3) : 120-123.

二级参考文献91

共引文献107

同被引文献19

引证文献2

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部